Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Picato 0.015% Gel for Cosmetic Improvement of Photoaged Skin
NCT03508856Completed
- Sponsor
- Skin Laser & Surgery Specialists of New York and New Jersey
- Start
- Nov 2015
- Primary completion
- Aug 2016
- Modality
- Peptides, Small Molecules
01
Overview
Open-label, single-arm trial of ingenol mebutate in actinic keratosis (AK) and photoaging of skin, sponsored by Skin Laser & Surgery Specialists of New York and New Jersey. Primary endpoint: Improvement in actinic keratoses and photoaged skin as measured numerically by Griffiths' Photonumeric Photoaging scale and questionnaires at 60 days. Started Nov 2015; status: completed.
02
Drugs
ingenol mebutate
03
Conditions
actinic keratosis (AK)photoaging of skin
Beyond the preview
Go deeper on NCT03508856.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03508856.